SEC Company Response from REPLIGEN CORP (RGEN) (CIK 0000730272) (RGEN) — Mar 13, 2007
REPLIGEN CORP (RGEN) (CIK 0000730272)
Date: March 13, 2007 · CIK: 0000730272 · Accession: 0001193125-07-053259
AI Filing Summary & Sentiment
Referenced dates: March 5, 2007
Show Raw Text
CORRESP
1
filename1.htm
SEC RESPONSE LETTER
RepliGen
Repligen Corporation
41 Seyon
Street, Bldg #1
Waltham, MA 02453-8335
Telephone: 781-250-0111
Telefax : 781-250-0115
March 13, 2007
United States Securities and
Exchange Commission
Division of Corporation Finance
100 F
Street, N.E.
Washington, D.C. 20549-7010
Attention: Jim B.
Rosenberg / Mark Brunhofer
Re:
Repligen Corporation
Form 10-K for Fiscal Year Ended March 31, 2006 : File No. 0-14656
Dear Gentlemen:
This letter is being furnished on behalf of Repligen Corporation (the “Company”) in
response to comments in the letter dated March 5, 2007 (the “Letter”) from Jim B. Rosenberg of the Staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) to Walter C.
Herlihy, President and Chief Executive Officer of the Company, with respect to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2006 (the “Form 10-K”) that was filed with the Commission on
June 9, 2006.
We respectfully request an extension of time until April 5, 2007 to provide our response. This will provide the time needed to
fully and adequately prepare and review the response with all applicable parties. Thank you for your consideration in this matter.
If you require
additional information, please telephone the undersigned at (781) 419-1850.
Sincerely,
/s/ Daniel W. Muehl
Daniel W. Muehl
Chief Financial Officer
Repligen Corporation